No definition available.
Liposarcoma, excluding all cancers (controls excluding all cancers)
C3_LIPOSARCOMA_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
342 |
4. Check minimum number of eventsNone |
342 |
5. Include endpointsNone |
342 |
6. Filter based on genotype QC (FinnGen only) |
342 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Liposarcoma, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 342 | 135 | 207 |
| Unadjusted period prevalence (%) | 0.07 | 0.05 | 0.09 |
| Median age at first event (years) | 62.45 | 59.80 | 64.18 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 216
- Matched controls
- 2159
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C49.22
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including hip liposarcoma
+∞
67.3
61
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
128.0
54.9
57
6
C48.02
ICD-10 Finland
Malignant tumor of the retroperitoneal space liposarcoma
+∞
54.5
50
*
130
Kela drug reimbursment
Malignant tumour
+∞
54.5
50
*
8850/3-C49.2
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
53.4
49
*
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
45.4
42
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
+∞
42.1
39
*
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
+∞
39.8
37
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
31.2
34.0
45
18
H02AB02
ATC
dexamethasone; systemic
52.5
33.1
39
9
JN4BD
NOMESCO Finland
Extensive body CT
16.0
32.3
54
44
A04AA02
ATC
granisetron; systemic, transdermal
120.0
29.5
31
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.4
29.5
145
595
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
320.8
28.5
28
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
12.5
27.4
51
52
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
307.2
27.4
27
*
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
+∞
25.5
24
*
WX408
NOMESCO Finland
General anesthesy, balanced
5.1
24.0
95
290
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
32.6
23.9
31
11
B01AB05
ATC
enoxaparin; parenteral
4.7
23.6
104
353
XX3DW
NOMESCO Finland
Time consuming IT work
12.5
23.4
43
42
8850/3-C49.6
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
23.3
22
*
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
+∞
23.3
22
*
ZXE10
NOMESCO Finland
More than one and less than three hours
4.4
23.3
121
481
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
134.3
23.1
24
*
D17.2
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
33.2
22.5
29
10
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
22.3
21
*
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
89.7
22.2
24
*
B01AB10
ATC
tinzaparin; parenteral
12.7
22.0
40
38
A03FA01
ATC
metoclopramide; systemic, rectal
7.0
22.0
59
110
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
21.2
20
*
8850/3-C49.1
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
20.1
19
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
20.1
19
*
WX402
NOMESCO Finland
General anaesthesia
5.5
19.6
65
157
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
12.4
19.3
35
33
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
19.0
18
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.1
18.4
89
314
C49.12
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder liposarcoma
+∞
18.0
17
*
8858/3-C48.0
ICD-O-3
Dedifferentiated liposarcoma of retroperitoneum
+∞
18.0
17
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
18.0
17
*
C49.42
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen liposarcoma
+∞
18.0
17
*
JN4AD
NOMESCO Finland
Body CT examination
10.6
16.9
33
36
R4110
NOMESCO Finland
Physiotherapy
3.9
16.9
89
332
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
16.9
16
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
15.8
15
*
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
+∞
15.8
15
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
171.9
15.7
16
*
ZXD10
NOMESCO Finland
Scheduled procedure
3.3
15.1
113
541
ZXE20
NOMESCO Finland
More than three and less than five hours
4.8
15.1
55
144
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
20.2
15.0
22
12
WF002
NOMESCO Finland
Radical radiotherapy
86.1
14.8
16
*
8850/3-C48.0
ICD-O-3
Liposarcoma, NOS, of retroperitoneum
+∞
14.7
14
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
14.7
14
*
L03AA02
ATC
filgrastim; parenteral
+∞
14.7
14
*
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
+∞
14.7
14
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
14.7
14
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
14.7
14
*
TPH07
NOMESCO Finland
Cathetrisation of artery
5.6
14.2
43
91
C49.2
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of lower limb, including hip
+∞
13.7
13
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
149.0
13.6
14
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
7.6
13.6
32
48
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.2
12.9
42
96
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.7
12.9
30
44
WX306
NOMESCO Finland
Lumbar epidural anesthesy
8.9
12.8
27
34
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
12.6
12
*
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
9.3
12.2
25
30
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
11.5
12.1
22
21
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
24.5
11.8
16
7
A04AA01
ATC
ondansetron; systemic, rectal
12.8
11.6
20
17
C49.32
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax liposarcoma
+∞
11.6
11
*
8850/3-C49.4
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
11.6
11
*
KAC00
NOMESCO Finland
Nephrectomy
+∞
11.6
11
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
11.6
11
*
C49.10
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder without histology
+∞
11.6
11
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
8.2
11.3
25
34
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
7.9
11.1
25
35
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
19.1
10.9
16
9
JN4CD
NOMESCO Finland
Very extensive body CT
15.3
10.7
17
12
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
115.4
10.5
11
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
115.4
10.5
11
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
115.4
10.5
11
*
Z51.5
ICD-10 Finland
Palliative care
11.5
10.5
19
18
C48.0
ICD-10 Finland
Malignant neoplasm: Retroperitoneum
+∞
10.5
10
*
C49.52
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis liposarcoma
+∞
10.5
10
*
C48.09
ICD-10 Finland
Malignant tumor of the retroperitoneal space other or unspecified tumor
+∞
10.5
10
*
A04AD12
ATC
aprepitant; systemic
+∞
10.5
10
*
8852/3-C49.2
ICD-O-3
Myxoid liposarcoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
10.5
10
*
N02AA05
ATC
oxycodone; systemic
3.9
10.1
43
128
N02BE01
ATC
paracetamol; systemic, rectal
3.5
10.0
192
1496
S18
ICPC
Laceration/cut
2.6
10.0
109
611
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
12.2
9.7
17
15
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
12.2
9.7
17
15
WZC30
NOMESCO Finland
Teaching
4.3
9.7
37
100
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
9.4
9.5
19
22
D17.9
ICD-10 Finland
Benign lipomatous neoplasm, unspecified
22.9
9.5
13
6
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
+∞
9.4
9
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
9.4
9
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
9.4
9
*
R4120
NOMESCO Finland
Occupational therapy
4.9
9.4
31
72
TPX10
NOMESCO Finland
Implantation of vascular injection port
12.3
8.7
15
13
ZXA05
NOMESCO Finland
Left side
2.6
8.7
77
379
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
17.2
8.7
13
8
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.2
8.6
49
183
ZXE00
NOMESCO Finland
One hour or less
2.4
8.5
98
553
NBR20
NOMESCO Finland
Intralesional or marginal excision of soft tissue tumour of shoulder or upper arm
93.6
8.5
9
*
JAH00
NOMESCO Finland
Laparotomy
11.4
8.4
15
14
C49.02
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck liposarcoma
+∞
8.4
8
*
116
Kela drug reimbursment
Prostate cancer
+∞
8.4
8
*
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
+∞
8.4
8
*
C49.62
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the trunk, unspecified localization liposarcoma
+∞
8.4
8
*
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
23.1
8.1
11
5
Z3226
NOMESCO Finland
Physiotherapist
2.9
8.0
54
223
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
13.7
8.0
13
10
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
10.0
7.9
15
16
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
15.8
7.8
12
8
ZX070
NOMESCO Finland
Intensity modified radiotherapy
82.8
7.5
8
*
NAR20
NOMESCO Finland
Complete excision of soft tissue tumour of spine, unspecified
82.8
7.5
8
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
82.8
7.5
8
*
ZXA00
NOMESCO Finland
Right side
2.4
7.4
74
384
8851/3-C49.2
ICD-O-3
Liposarcoma, well differentiated, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
7.3
7
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
7.3
7
*
ZZR10
NOMESCO Finland
Flap of skin and muscle
+∞
7.3
7
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
7.3
7
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.7
7.0
19
36
L02AE02
ATC
leuprorelin; implant, parenteral
23.4
6.7
9
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
10.5
6.6
12
12
TQW99
NOMESCO Finland
Other minor procedure on skin
6.6
6.6
16
26
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.7
6.6
21
48
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
6.5
44
182
WW500
NOMESCO Finland
Blood transfusion
8.6
6.4
13
16
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
6.3
6
*
115
Kela drug reimbursment
Breast cancer
+∞
6.3
6
*
ZZR30
NOMESCO Finland
Flap of muscle
+∞
6.3
6
*
C49.19
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder other or unspecified tumor
+∞
6.3
6
*
8850/3-C49.5
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of pelvis
+∞
6.3
6
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
6.3
6
*
C49.99
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue other or unspecified tumor
+∞
6.3
6
*
ZZR00
NOMESCO Finland
Flap of skin
27.6
6.3
8
*
WX320
NOMESCO Finland
Spinalanesthesy
2.4
6.2
57
282
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
90
77
15.51
92.35
1.5
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
90
193
5.97
42.07
1.7
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
194
797
4.31
39.72
3.0
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
225
1151
3.79
30.92
5.9
3.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
170
762
3.45
28.08
3.6
2.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
61
143
4.97
25.09
3.3
1.6
ug/l
3.2
4.8
0.36
50
112
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
138
595
3.21
23.46
3.6
2.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
150
711
2.98
21.16
5.2
3.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
190
1102
2.63
17.12
11.0
9.9
inr
1.3
1.4
0.65
61
293
(3024561) Albumin [Mass/volume] in Serum or Plasma
189
1122
2.53
15.80
7.4
3.8
g/l
34.3
35.9
3.09
176
1051
(3013650) Neutrophils [#/volume] in Blood by Automated count
223
1433
2.60
15.69
14.7
6.4
e9/l
4.4
4.3
0.23
203
1239
(40758558) Short blood count panel - Blood
120
581
2.64
15.34
10.7
4.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
69
251
3.19
14.95
4.4
2.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
49
143
3.83
14.91
9.4
7.9
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
106
520
2.50
12.86
2.5
2.1
e6/l
5.9
4.2
0.50
93
452
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
46
143
3.56
12.71
10.5
7.8
mmol/l
24.2
24.8
0.64
46
129
(3002173) Hemoglobin [Mass/volume] in Arterial blood
68
269
2.91
12.61
8.8
6.8
g/l
118.6
124.3
1.59
68
262
(3003396) Base excess in Arterial blood by calculation
77
326
2.76
12.57
8.2
6.2
mmol/l
0.2
1.3
1.76
68
246
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
185
1165
2.28
12.55
8.0
5.0
mmol/l
1.2
1.2
0.84
173
1042
(3027801) Oxygen [Partial pressure] in Arterial blood
76
321
2.76
12.46
8.4
6.2
kpa
14.1
12.1
2.32
76
308
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
76
321
2.76
12.46
8.4
6.3
kpa
5.2
5.1
0.65
76
306
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
195
1262
2.27
12.30
8.6
5.6
mmol/l
1.2
1.2
1.91
164
1100
(36304419) Bacteria [Presence] in Urine
129
707
2.32
12.10
3.1
2.7
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
70
289
2.79
11.95
8.4
6.5
%
97.2
95.3
3.44
70
279
(3030467) Casts [#/volume] in Urine by Automated count
130
719
2.30
11.90
3.2
2.8
e6/l
0.6
0.4
0.17
100
521
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
271
2041
2.58
11.68
12.6
5.3
u/l
83.4
75.1
2.24
264
1878
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
98
493
2.38
11.05
4.8
2.1
mmol/l
2.5
2.4
1.08
83
419
(3013826) Glucose [Moles/volume] in Serum or Plasma
227
1608
2.22
10.89
6.6
4.1
mmol/l
6.9
6.8
0.46
222
1493
(3002582) Erythrocytes [#/volume] in Urine
134
786
2.16
10.33
3.3
2.9
e6/l
21.1
158.5
0.95
104
589
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
46
165
3.07
10.06
1.3
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
29
78
3.97
9.82
2.9
2.5
u/ml
0.3
0.3
0.03
15
41
(3015377) Calcium [Moles/volume] in Serum or Plasma
137
825
2.10
9.74
7.2
2.1
mmol/l
2.4
2.4
0.04
118
679
(3018418) pH of Serum or Plasma
125
731
2.12
9.57
5.8
3.2
ph
7.4
7.4
1.22
31
109
(3026782) Osmolality of Urine
94
500
2.21
9.09
2.6
2.3
mosm/kgh2o
525.8
577.7
1.38
77
413
(3000991) Gas panel - Venous blood
54
229
2.61
8.63
10.9
6.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
145
923
1.99
8.61
3.8
3.4
e6/l
54.0
90.9
0.68
110
639
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
147
959
1.93
7.97
3.3
2.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
167
1164
1.85
7.17
12.7
7.6
e9/l
0.0
0.0
0.72
144
941
(42870588) Differential panel, method unspecified - Blood
130
843
1.87
6.97
5.9
5.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
312
2715
2.70
6.69
24.9
12.3
mg/l
34.6
23.9
5.34
280
2106
(3014111) Lactate [Moles/volume] in Serum or Plasma
52
244
2.33
6.65
9.6
5.5
mmol/l
1.0
1.5
5.18
52
236
(3042936) Bacteria identified in Isolate by Culture
72
387
2.09
6.60
2.1
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
105
649
1.89
6.45
1.4
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
60
306
2.17
6.28
2.0
1.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
126
835
1.81
6.15
3.7
2.7
u/l
30.9
31.8
0.16
120
789
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
17
44
4.01
6.06
1.3
1.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
179
1318
1.75
6.05
5.9
5.0
e9/l
2.1
1.8
0.31
158
1143
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
53
261
2.22
6.04
3.6
2.8
u/l
211.4
235.5
1.64
53
242
(3013115) Eosinophils [#/volume] in Blood
181
1341
1.74
5.95
6.1
5.3
e9/l
0.2
0.2
0.69
161
1168
(40761536) Microorganisms panel - Urine sediment
43
197
2.35
5.80
5.5
2.9
—
—
—
0
0
(3044889) 12 lead EKG panel
245
1988
1.82
5.78
4.5
3.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
175
1302
1.70
5.53
6.0
5.0
e9/l
0.0
0.0
0.83
153
1122
(3001604) Monocytes [#/volume] in Blood
174
1293
1.70
5.51
6.0
5.0
e9/l
0.6
0.6
0.81
154
1108
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
42
195
2.32
5.50
3.7
1.9
ml/min/173m2
53.9
63.4
0.89
14
79
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
13
30
4.47
5.34
1.2
1.2
pmol/l
75.6
61.4
0.53
13
30
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
77
461
1.87
5.11
2.8
2.6
e6/l
0.9
1.0
0.13
41
255
(3017181) Myelocytes/100 leukocytes in Blood
38
179
2.26
4.81
3.5
4.2
%
1.1
0.9
0.19
19
38
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
124
867
1.67
4.77
2.4
2.1
u/l
61.7
56.5
0.38
117
799
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
38
3.80
4.69
1.4
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
36
168
2.28
4.66
3.5
4.3
%
0.1
0.1
0.04
19
33
(3026008) Bacteria identified in Urine by Culture
106
715
1.70
4.65
3.1
3.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
162
1220
1.62
4.61
6.7
5.4
%
24.8
27.2
1.42
154
1135
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
7
5
14.25
4.59
1.9
1.0
nmol/l
66.1
70.2
—
7
5
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
97
644
1.71
4.49
2.2
2.1
mg/l
3.2
3.0
0.17
87
545
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
71
431
1.82
4.47
3.0
2.8
e6/l
2.1
2.1
0.00
36
226
(3022096) Basophils/100 leukocytes in Blood
155
1162
1.61
4.45
6.6
5.2
%
0.6
0.7
2.72
148
1087
(3006504) Eosinophils/100 leukocytes in Blood
158
1194
1.60
4.36
6.8
5.2
%
2.5
3.1
2.36
152
1116
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
55
310
1.92
4.36
1.7
1.8
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
158
1198
1.59
4.28
7.1
5.5
%
9.0
8.7
0.58
152
1123
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
55
312
1.91
4.27
1.7
1.8
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
18
63
2.96
4.13
1.3
1.3
ug/g
221.1
320.3
—
10
39
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
70
434
1.77
4.09
1.9
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
167
1295
1.57
4.03
4.2
3.4
estimate
0.0
0.0
0.00
41
214
(3021601) Nitrite [Presence] in Urine by Test strip
167
1297
1.56
3.99
5.3
4.8
estimate
0.0
0.0
0.00
38
213
(3019550) Sodium [Moles/volume] in Serum or Plasma
316
2893
2.21
3.85
27.3
15.0
mmol/l
139.4
139.8
2.15
310
2806
(3018010) Neutrophils/100 leukocytes in Blood
157
1213
1.54
3.78
6.4
5.2
%
59.3
57.8
0.75
148
1139
(3023103) Potassium [Moles/volume] in Serum or Plasma
316
2902
2.17
3.67
27.6
15.0
mmol/l
4.0
4.0
0.51
310
2812
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
290
2591
1.78
3.66
24.9
11.1
ml/min/173m2
77.9
78.4
0.16
258
2087
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
85
575
1.64
3.59
1.9
1.7
mg/l
1.4
1.1
0.71
68
444
(3009261) Glucose [Presence] in Urine by Test strip
167
1320
1.52
3.55
4.2
3.5
estimate
0.0
0.0
0.00
39
209
(3025159) Blasts/100 leukocytes in Blood
32
160
2.10
3.53
3.7
4.4
%
0.1
0.0
0.16
16
29
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
13
6.27
3.52
2.4
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
32
161
2.09
3.48
3.6
4.2
%
0.9
0.3
0.83
14
27
(1616796) Gas panel - Central venous blood
13
42
3.18
3.40
2.0
2.9
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
7
10
7.12
3.38
1.9
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
96
688
1.55
3.14
4.8
3.6
estimate
0.0
0.0
0.50
38
202
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
34
3.31
3.08
2.2
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
29
3.52
3.07
2.3
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
21
4.37
3.01
2.2
1.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
9
6.76
2.88
2.0
2.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
52
331
1.67
2.76
1.5
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
6
8.43
2.76
1.2
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
10
6.08
2.71
2.8
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
10
6.08
2.71
2.8
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
78
551
1.54
2.70
5.1
3.9
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
315
2940
1.90
2.70
30.5
14.6
umol/l
84.3
81.4
0.85
315
2940
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
24
3.82
2.69
1.4
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
32
3.19
2.66
2.1
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
129
1016
1.43
2.58
4.4
3.6
—
—
—
0
0
(3010421) pH of Blood
14
56
2.56
2.56
3.3
2.9
ph
7.4
7.4
0.11
14
44
(3043410) Blood group antigens tested for on Red Blood Cells
5
7
7.23
2.55
3.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
11
5.53
2.55
1.7
1.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
212
1827
1.42
2.53
4.9
3.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
78
560
1.51
2.49
3.7
3.9
ng/l
53.7
453.6
3.02
67
457
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
16
4.44
2.48
2.6
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
13
51
2.61
2.47
2.0
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
271
2451
1.51
2.46
27.5
13.7
%
38.4
40.1
2.25
197
1683
(3035880) pH of Pleural fluid
5
8
6.32
2.38
1.2
1.8
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
17
4.18
2.37
1.3
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
41
2.74
2.30
2.5
2.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
57
389
1.56
2.29
24.8
24.6
inr
1.6
1.4
—
8
51
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
23
3.54
2.28
2.8
3.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
230
2030
1.41
2.27
3.6
4.0
mm/h
14.8
11.7
1.64
208
1867
(3022145) Colonoscopy Study observation
42
267
1.65
2.25
1.3
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
9
5.62
2.22
2.0
1.9
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
36
2.83
2.22
2.1
1.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
10
36
2.83
2.22
1.0
1.3
u/ml
3.2
10.8
—
5
17
(3001122) Ferritin [Mass/volume] in Serum or Plasma
133
1076
1.39
2.22
2.7
2.6
ug/l
239.6
127.8
1.33
126
988
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
28
159
1.83
2.21
1.3
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
12
48
2.55
2.21
2.1
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
6
14
4.34
2.16
2.0
1.6
e9/l
0.6
0.8
—
6
7
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
55
2.42
2.15
1.5
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
37
2.75
2.12
2.1
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
16
75
2.19
2.12
1.1
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
43
2.61
2.11
2.0
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
84
632
1.44
2.11
3.7
3.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
24
132
1.88
2.10
1.0
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
31
185
1.74
2.09
6.6
6.7
mmol/l
24.8
24.3
0.59
31
172
(40761511) CBC panel - Blood by Automated count
307
2881
1.64
2.07
22.1
11.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
10
38
2.68
2.02
5.2
2.6
%
63.2
58.8
—
10
38
(3052851) Hemolysis interference index of Serum or Plasma
15
70
2.20
2.01
2.3
3.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
313
2959
1.68
1.95
15.4
8.8
u/l
27.3
26.0
0.67
302
2843
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
28
167
1.74
1.91
1.6
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
34
2.69
1.88
1.0
1.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
9
34
2.69
1.88
1.0
1.3
—
3.7
—
0
10
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
23
130
1.82
1.87
5.3
3.9
mmol/l
23.2
24.5
1.34
23
117
(3012441) Differential panel - Pleural fluid
6
17
3.57
1.84
1.2
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
15
73
2.10
1.83
1.5
1.7
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
109
1.89
1.81
2.3
1.3
g/l
3.2
3.9
2.44
15
72
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
109
1.89
1.81
2.3
1.3
g/l
8.0
7.6
0.27
15
76
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
109
1.89
1.81
2.3
1.3
—
—
—
0
0
(4306422)
9
36
2.54
1.75
1.1
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
320
3056
1.73
1.73
36.6
18.2
e9/l
254.8
242.2
2.47
313
2960
(3051651) Icteric interference index of Serum or Plasma
5
13
3.89
1.72
2.8
3.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
34
221
1.60
1.70
7.5
7.2
mmol/l
11.8
10.3
0.51
34
210
(3024731) MCV [Entitic volume]
320
3058
1.72
1.70
36.3
18.2
fl
91.0
91.3
0.64
315
2999
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
55
2.22
1.69
1.3
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
320
3059
1.72
1.68
36.5
18.2
e12/l
4.4
4.5
5.38
312
2946
(3035941) MCH [Entitic mass]
320
3059
1.72
1.68
36.3
18.1
pg
30.1
30.5
3.13
315
3000
(3000963) Hemoglobin [Mass/volume] in Blood
320
3059
1.72
1.68
36.7
18.3
g/l
130.2
137.9
12.07
315
2998
(4024509)
6
19
3.19
1.67
2.5
1.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
320
3060
1.71
1.66
36.6
18.2
e9/l
7.4
6.6
2.08
312
2950
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
25
2.84
1.66
1.6
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
18
98
1.88
1.65
1.5
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
111
908
1.33
1.65
3.3
2.9
ng/l
1843.3
1471.1
0.42
99
774
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
14
3.61
1.62
1.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
14
3.61
1.62
2.0
2.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
39
266
1.53
1.60
4.0
3.3
mmol/l
1.2
1.9
0.77
33
217
(4268621)
7
26
2.73
1.59
2.0
2.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
6
20
3.03
1.59
1.0
1.1
—
3.3
—
0
5
(3019060) Gas panel - Arterial blood
29
185
1.62
1.57
4.7
4.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
33
2.46
1.54
1.1
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
17
93
1.87
1.54
2.1
1.7
ug/l
0.2
1.8
1.68
17
82
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
27
2.62
1.52
1.0
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
79
1.94
1.52
1.7
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
24
373
0.62
1.49
3.8
4.8
%
29.3
31.5
0.56
15
255
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
37
2.47
1.49
4.3
2.0
e9/l
4.1
4.4
—
9
37
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
38
2.40
1.46
1.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
16
3.16
1.44
1.6
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
22
2.76
1.44
2.7
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
17
2.97
1.36
1.2
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
83
1.84
1.33
1.8
3.9
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
43
2.12
1.31
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
43
2.12
1.31
1.2
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
24
2.53
1.31
1.0
1.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
20
312
0.62
1.28
1.4
1.8
%
1.4
1.6
0.74
15
271
(3047181) Lactate [Moles/volume] in Blood
15
85
1.80
1.25
5.7
5.5
mmol/l
1.4
1.2
0.48
15
77
(3016018) Differential panel - Cerebral spinal fluid
6
25
2.42
1.25
1.5
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
7
141
0.49
1.24
7.0
3.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
86
705
1.29
1.23
4.3
3.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
19
2.65
1.22
1.4
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
19
2.65
1.22
1.0
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
91
754
1.28
1.20
2.6
2.5
umol/l
382.8
9083.3
3.82
76
654
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
62
775
0.76
1.19
1.6
1.7
mmol/l
1.5
1.4
0.57
44
638
(3022806) Fractional oxyhemoglobin in Capillary blood
6
26
2.33
1.19
4.2
1.5
%
88.2
90.5
—
6
26
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
57
1.96
1.18
1.7
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
30
2.36
1.13
1.9
2.9
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
8
41
1.97
1.09
1.1
2.0
g/l
0.8
1.0
—
8
35
(3051611) Lipemic interference index of Serum or Plasma
5
21
2.40
1.09
3.0
3.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
32
2.21
1.08
1.0
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
59
1.89
1.08
1.1
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
33
2.14
1.06
1.3
1.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
18
114
1.61
1.05
5.5
4.3
%
0.9
0.9
0.21
18
109
(3000034) Microalbumin [Mass/volume] in Urine
0
30
0.00
0.97
0.0
2.6
—
10.9
—
0
24
(3024928) Oxygen saturation in Venous blood
12
69
1.77
0.97
3.2
2.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
9
50
1.82
0.97
1.1
1.5
—
—
—
0
0
(4010399)
29
210
1.42
0.94
1.3
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
27
2.24
0.94
2.5
3.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
12
70
1.74
0.94
1.3
1.3
—
—
—
0
0
(3000492) Spirometry study
33
246
1.38
0.91
1.5
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
268
2801
0.80
0.90
4.1
4.7
mmol/l
4.5
4.5
0.18
243
2596
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
29
2.09
0.89
1.5
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
30
2.02
0.87
1.5
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
30
2.02
0.87
1.5
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
30
2.02
0.87
1.5
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
30
2.02
0.87
1.5
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
30
2.02
0.87
1.5
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
46
365
1.30
0.86
1.1
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
192
1772
1.19
0.85
3.4
3.0
u/l
68.1
48.0
0.86
181
1658
(3049717) Cytology report of Urine Cyto stain
14
89
1.60
0.82
2.7
1.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
31
236
1.34
0.77
2.2
2.3
e9/l
70.6
65.4
0.30
21
181
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
24
2.10
0.75
1.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
24
2.10
0.75
1.2
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
217
2037
1.18
0.75
4.0
3.5
pmol/l
14.8
14.9
0.25
194
1850
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
267
2777
0.82
0.74
4.0
4.7
mmol/l
1.4
1.4
2.07
238
2563
(21494755) Public health laboratory ask at order entry panel
14
206
0.67
0.74
1.4
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
25
2.01
0.73
1.2
1.6
%
11.1
11.0
—
5
25
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
1.8
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
39
1.81
0.73
1.1
2.6
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
10
60
1.69
0.73
2.3
1.4
iu/l
8.0
4.6
—
5
21
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
68
1.64
0.72
1.2
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
43
347
1.27
0.72
1.5
1.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
17
118
1.46
0.70
5.8
4.3
%
1.7
1.6
0.28
17
113
(3024891) Influenza virus A+B Ag [Presence] in Specimen
10
61
1.66
0.69
1.0
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
19
136
1.42
0.68
1.3
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
91
0.54
0.68
1.8
1.8
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
10
62
1.63
0.65
1.3
1.2
mmol/l
3.6
3.9
—
10
57
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
29
1.73
0.64
1.2
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
13
187
0.68
0.63
4.6
3.7
kpa
5.0
5.1
0.35
13
171
(40760888) Immunoglobulin light chains.free panel - Serum
8
50
1.61
0.61
2.0
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
30
1.68
0.61
1.0
1.2
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
0
20
0.00
0.60
0.0
1.1
—
39.0
—
0
20
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
35
1.73
0.58
1.2
1.5
—
—
—
0
0
(3020891) Body temperature
16
115
1.41
0.57
3.9
4.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
55
1.47
0.56
3.8
2.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
8
124
0.64
0.55
6.0
4.2
mmol/l
25.4
25.1
—
8
114
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
33
268
1.26
0.55
1.2
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
54
463
1.20
0.55
1.2
1.3
iu/ml
39.2
35.1
0.07
17
134
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
60
1.51
0.54
1.3
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
13
91
1.45
0.53
2.8
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
13
180
0.71
0.53
1.5
1.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
35
288
1.24
0.53
2.7
2.2
ug/g
180.1
122.7
0.47
30
233
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
40
1.51
0.52
1.8
2.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
40
1.51
0.52
1.2
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
55
476
1.19
0.51
1.7
1.3
g/l
2.5
2.7
0.40
35
283
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
13
93
1.41
0.49
2.5
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
114
1048
1.13
0.48
2.2
2.2
nmol/l
74.4
76.9
0.44
103
915
(3021960) Folate [Moles/volume] in Serum or Plasma
77
690
1.15
0.47
1.5
1.5
nmol/l
21.7
20.3
0.29
66
584
(3008898) HLA-B27 [Presence]
5
85
0.58
0.46
1.0
1.1
—
—
—
0
0
(1002224) Polysomnography panel
16
121
1.34
0.45
1.1
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
40
341
1.20
0.44
1.4
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
22
175
1.27
0.44
2.1
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
32
1.57
0.42
2.0
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
12
161
0.74
0.42
1.5
1.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
15
0.00
0.41
0.0
1.1
—
40.4
—
0
9
(3032773) Endomysium IgG Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
15
0.00
0.41
0.0
1.1
—
7.6
—
0
15
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
11
79
1.41
0.41
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
79
1.41
0.41
1.2
1.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
2.1
—
1.1
—
0
10
(3014271) Vancomycin [Susceptibility]
0
17
0.00
0.40
0.0
2.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
10
71
1.42
0.39
1.3
1.3
mg/l
812.1
512.3
—
10
66
(42529406) Shigella sp [Presence] in Stool by Culture
11
80
1.39
0.39
1.2
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
279
2854
0.88
0.38
4.6
5.3
mmol/l
2.7
2.7
0.20
251
2633
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
13
99
1.33
0.36
1.4
1.5
mg/l
3.4
2.7
—
7
72
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
79
0.63
0.36
1.2
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
45
1.34
0.34
1.0
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
28
238
1.19
0.33
1.3
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
67
610
1.12
0.33
3.8
3.8
kg/l
1.0
1.0
0.91
13
97
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
270
2761
0.90
0.33
4.7
4.7
mmol/l
6.2
6.0
0.68
240
2517
(3013139) Helicobacter pylori Ag [Presence] in Stool
21
175
1.21
0.31
1.4
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
54
1.30
0.30
1.6
1.2
—
—
—
0
0
(3013512) EKG study
92
858
1.10
0.30
4.0
3.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
103
966
1.09
0.30
2.6
3.1
mmol/l
7.3
7.8
0.53
86
807
(3019230) Fractional oxyhemoglobin in Venous blood
7
56
1.26
0.29
1.4
1.8
%
60.4
63.2
—
7
56
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
13
162
0.79
0.29
1.4
1.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
12
94
1.29
0.28
1.1
1.0
—
—
—
0
0
(3019225) pH of Specimen
29
253
1.16
0.27
3.9
3.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
262
2674
0.91
0.26
3.7
4.2
mmol/l
1.4
1.3
0.84
231
2449
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
257
2517
1.08
0.24
4.6
4.4
mu/l
1.8
2.0
0.81
229
2289
(3012516) Albumin [Mass/volume] in Urine
98
927
1.08
0.23
2.8
3.2
mg/l
375.4
123.1
0.34
66
611
(36660697) Celiac disease serology panel - Serum
22
190
1.17
0.23
1.1
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
14
116
1.22
0.22
2.6
1.9
u/l
37.9
39.2
0.09
14
100
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
13.0
—
0.7
—
0
11
(4015189)
0
11
0.00
0.21
0.0
2.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
8.9
—
0
12
(3021901) Oxygen saturation in Capillary blood
5
43
1.17
0.21
1.6
2.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
123
1179
1.07
0.21
1.9
2.0
pmol/l
94.8
94.5
0.02
69
613
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
57
611
0.92
0.20
1.7
1.7
pmol/l
150000378.0
7828212.1
0.46
48
511
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
109
1042
1.07
0.20
4.6
3.8
%
21.6
24.0
0.90
55
500
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
40
366
1.11
0.20
10.1
7.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
6
53
1.13
0.19
2.2
2.6
kpa
8.0
7.8
—
6
47
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
159
1544
1.06
0.17
2.8
2.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
101
1.19
0.17
2.8
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
14
120
1.17
0.16
1.4
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
26
235
1.12
0.16
3.8
3.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
52
553
0.93
0.16
1.9
1.8
nmol/l
1162.3
1187.2
0.05
38
432
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
41
440
0.92
0.15
1.2
1.2
u/ml
5.4
8.2
0.31
14
158
(1761482) Bacteria [#/volume] in Urine by Culture
9
81
1.11
0.15
3.7
3.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
112
1.17
0.14
1.1
1.0
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
9
106
0.84
0.13
1.4
1.6
—
132.0
—
0
5
(4034850)
9
108
0.83
0.13
6.8
12.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
118
1146
1.05
0.12
4.1
3.6
ng/l
45.9
43.0
0.09
101
832
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
17
153
1.12
0.11
1.5
2.2
%
1.0
1.1
0.40
17
153
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
264
2668
0.95
0.11
5.5
6.2
mmol/mol
40.3
40.3
0.00
239
2482
(3037756) Immunofixation for Serum or Plasma
5
44
1.14
0.10
1.0
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
133
1301
1.04
0.10
5.0
3.9
ug/l
2.1
2.0
0.20
119
1166
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
47
1.06
0.09
1.8
2.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
37
351
1.06
0.09
1.1
1.3
titre
628.6
378.5
—
7
80
(3001019) Free T4 and TSH panel - Serum or Plasma
12
107
1.13
0.08
1.2
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
29
273
1.07
0.08
1.4
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
5
61
0.82
0.08
1.4
2.4
umol/l
28.6
34.6
—
5
54
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
88
1.14
0.08
1.3
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
50
520
0.95
0.08
1.2
1.3
u/ml
0.6
2.0
2.16
11
146
(3015171) Extractable nuclear Ab [Units/volume] in Serum
11
98
1.13
0.07
1.2
1.2
—
0.3
—
0
7
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
21
225
0.93
0.07
1.4
1.8
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
8
76
1.05
0.07
1.0
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
75
730
1.04
0.07
2.8
2.7
ug/l
0.6
0.7
0.77
59
476
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
15
163
0.92
0.07
1.1
1.3
—
—
—
0
0
(4094501)
9
87
1.04
0.07
1.0
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
8
93
0.86
0.07
2.3
1.7
nmol/l
39.1
43.4
—
8
88
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
29
301
0.96
0.04
1.8
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
15
159
0.94
0.03
1.1
1.2
iu/ml
23.6
105.0
—
5
62
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
167
0.96
0.01
1.7
2.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
18
178
1.01
0.00
3.5
3.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
98
981
1.00
0.00
3.5
4.0
mg/mmol
7.8
8.1
0.03
64
636
(3000330) Specific gravity of Urine by Test strip
15
146
1.03
0.00
4.3
3.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
100
995
1.01
0.00
2.9
3.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
1479.3
—
0
9
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
7
69
1.01
0.00
2.1
1.7
mg/l
7.7
12.3
—
7
63
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
66
0.91
0.00
1.0
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
6.9
—
0
5
(3051101) Glucose [Moles/volume] in Cord blood
0
7
0.00
0.00
0.0
6.3
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
5
56
0.89
0.00
1.0
1.1
—
54.7
—
0
5
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
17.7
—
0
6
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
55
0.91
0.00
1.4
1.4
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
5
58
0.86
0.00
1.0
1.7
mu/l
343.6
258.3
—
5
52
(3044007) Cell count panel - Peritoneal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
56
0.89
0.00
1.6
1.5
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
49
1.02
0.00
1.8
2.5
mmol/l
4.3
4.1
—
5
49
(3019832) Treponema pallidum Ab [Presence] in Serum
14
140
1.00
0.00
1.0
1.5
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.5
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
3.8
—
7.8
—
0
5
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
49
1.02
0.00
1.8
2.5
mmol/l
105.2
106.1
—
5
49
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
18.7
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_LIPOSARCOMA_EXALLC – Liposarcoma, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).